BPIQ Blog

Dec 28, 20201 min read

Biopharma Daily Stock Updates - 12/28/20

$XBI $146.46 (-2.37%) 📉 COVID-19: $ARCT (-5.82%) - Approval to proceed with phase 2 study. https://ir.arcturusrx.com/news-releases/news-...

Dec 23, 20201 min read

$XBI $151.14 (+0.005%) 📈 COVID: $BNTX (-0.5%) - Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19...

Dec 22, 20201 min read

$CYDY - FDA Resumes eIND Approval for Severe-to-Critical COVID-19 Patients Use of Vyrologix™ (leronlimab) Following Full Enrollment in CytoD

Dec 21, 20201 min read

Orchard Therapeutics Receives EC Approval for Libmeldy™ for the Treatment of Early-Onset Metachromatic Leukodystrophy (MLD)

Dec 18, 20201 min read

$KPTI (+8.4%) - Karyopharm Announces FDA Approval of XPOVIO® (Selinexor) as a Treatment for Patients with Multiple Myeloma After At Least On

Dec 17, 20201 min read

Covid: $MRNA (+5%) - FDA ADCOM vote in favor of emergency use

Dec 16, 20201 min read

Data Updates: $AVDL (-8.5%) - Avadel Pharmaceuticals Announces Submission of New Drug Application for FT218 to the FDA

Dec 15, 20201 min read

$XBI $146.32 (+0.2%) Data Updates: $ATNX (-6%) - FDA approval of Klisyri (Tirbanibulin) https://ir.athenex.com/news-releases/news-release...

Dec 14, 20201 min read

$ALXN - AstraZeneca to Acquire Alexion, Accelerating the Company's Strategic and Financial Development

Dec 11, 20201 min read

Data Updates: $GILD (+0.5) - New Data From Phase 3 ASCENT Trial

Dec 10, 20201 min read

$BNTX (+3.66%) - Pfizer and BioNTech Announce Publication of Results from Landmark Phase 3 Trial of BNT162b2 COVID-19 Vaccine Candidate

Dec 9, 20201 min read

$GMDA (-13.3%) – Topline phase 3 results & BLA plans

Dec 8, 20201 min read

$MRNA (+6.5%) - Switzerland Exercises Increased Option for 7.5 Million Doses of mRNA-1273

Dec 7, 20201 min read

Presentations at 62nd American Society of Hematology Annual Meeting

Our platform helps you uncover your next biotech investment opportunity